Longevity & Regenerative Medicine
Independent assessment of therapies, platforms and clinical models in the longevity field — separating durable science from well-funded narrative.
We operate quietly, by referral, on a small number of engagements at a time — for principals who need clarity before capital, policy, or reputation is committed.
Independent assessment of therapies, platforms and clinical models in the longevity field — separating durable science from well-funded narrative.
Evaluation and design of AI-driven workflows, agentic systems and decision-support architectures — what the technology can actually carry today, and what it cannot.
Deep technical and analytical review of ventures, devices and research programs — for investors, founders and institutions on both sides of a decision.
Structured analysis of where converging technologies are taking a market, a regulatory regime, or an industry — five moves ahead of the public conversation.
No retainers sold from a brochure. No reports written to please. Each engagement begins with a single question that matters — and ends when it is answered with evidence.
We are deliberately small, deliberately discreet, and deliberately independent: we hold no positions in what we evaluate.
We take a limited number of engagements. Inquiries are reviewed personally; no automated replies, no mailing lists.